AI Stock Memo: MDT - Medtronic - RankAlpha

MDT

Rating buyAI Memo

Medtronic

As of 2026-02-19/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-02-19 • Model: RankAlpha Sentiment AI

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

buy

Confidence

medium

Horizon

—

Key catalyst

Regulatory/clinical readouts • 2026-08-19

Expected move: +52%

Biggest risk

Prolonged procedure weakness, adverse reimbursement or regulatory setbacks compress revenue and margins, pushing valuation toward the analyst low.

Invalidation

Break below $92 or thesis failure.

What would change my mind?

Procedure-volume recovery, successful clinical readouts and margin leverage drive revenue and EPS above consensus, supporting multiple expansion toward the analyst high and the bull target.

Research note

Recommendation

buy

Confidence

medium

As of

2026-02-19

Base target

$112

p=60%

Bull target

$127

p=20%

Bear target

$92

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Next quarterly earnings release
Margin expansion from product mix & cost actions
Procedure-volume recovery, successful clinical readouts and margin leverage drive revenue and EPS above consensus, supporting multiple expansion toward the analyst high and the bull target.

BearKey bullets

Adverse regulatory rulings or delayed approvals
Execution risk on cost actions and integration
Procedure-volume slowdown in core markets

WatchKey bullets

Regulatory/clinical readouts

Summary

High-level snapshot

Recommendation

buy

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $112 (p=60%)

Bull/Bear spread: +72% / +25%

Vs latest close: Bull +72% · Base +52% · Bear +25%

Scenario probabilities

Bull Target: $127 (p=20%)Base Target: $112 (p=60%)Bear Target: $92 (p=20%)

Commentary

Sentiment is cautiously constructive: analysts cluster around a ~112 USD twelve‑month median, implying upside from the current anchor. Near-term tone is data-driven (earnings, clinical readouts); longer-term conviction depends on margin recovery and product commercialization.

As of 2026-02-19 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Procedure-volume recovery, successful clinical readouts and margin leverage drive revenue and EPS above consensus, supporting multiple expansion toward the analyst high and the bull target.

Bear Case

Prolonged procedure weakness, adverse reimbursement or regulatory setbacks compress revenue and margins, pushing valuation toward the analyst low.

Drivers

Scannable catalysts and supporting factors

Next quarterly earnings release
Margin expansion from product mix & cost actions

Human Analyst Targets

External snippets for comparison only; verify at source.

Unverified externalLast fetched 2026-02-19Source quality: external scrape

External snippets are unverified; treat as directional signals only. Always confirm with the original provider.

Inline RA est

Provider

serper

Median (USD)

$111.92

Range (USD)

$92.00 - $127.05

Count

Query: Medtronic Plc Common (MDT) analyst consensus price target high low average

Medtronic (MDT) Stock Forecast & Price Target - Investing.com
Search result #1
According to projections from 25 analysts, the average 12-month price target for Medtronic is 112.00, with a high estimate of 121 and a low estimate of 100.
Open source
MDT Stock Forecast - Medtronic PLC - Alpha Spread
Search result #2
According to Wall Street analysts, the average 1-year price target for MDT is 112.06 USD with a low forecast of 92.92 USD and a high forecast of 127.05 USD.
Extracted: $112.06, $92.92, $127.05Open source
Medtronic (MDT) Stock Forecast, Price Targets and Analysts ...
Search result #3
The average price target is $113.12 with a high forecast of $121.00 and a low forecast of $103.00. The average price target represents a 13.70% change from the ...
Extracted: $113.12, $121.00, $103.00Open source
Medtronic plc. MDT Stock Forecast & Price Target - Yahoo Finance
Search result #4
Find the latest Medtronic plc. MDT analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Open source
Medtronic plc: Target Price Consensus and Analysts ...
Search result #5
Last Close Price. 96.41USD. Average target price. 111.92USD. Spread / Average Target. +16.09%. High Price Target. 125.00USD. Spread / Highest target. +29.65%.
Extracted: $96.41, $111.92, $125.00Open source
Medtronic plc Stock Price: Quote, Forecast, Splits & News (MDT)
Search result #6
Wall Street analysts maintain a consensus 'Moderate Buy' rating with a $111.21 price target, reflecting confidence in the medical device leader's growth ...
Extracted: $111.21Open source

Scenarios

Bull Target (Scenario probability)

$127 / p=20% prob

Base Target (Scenario probability)

$112 / p=60% prob

Bear Target (Scenario probability)

$92 / p=20% prob

Price $74 as of 2026-05-29

Nearest Scenario: Bear (∆ 25%)

Targets vs latest close: Bull +72% · Base +52% · Bear +25%

Sentiment & Exposure

Sentiment unavailable: insufficient coverage

Events

Other notable items detected

EVENT2026-08-19
Regulatory/clinical readouts
Pivotal readouts or regulatory decisions for key device programs can produce material moves; timing estimated conservatively.
Prob 30.00% • Move 10.00% • Priced-in 15.00%

Short-term Catalysts

Next few weeks

Next quarterly earnings release
2026-05-20
Quarterly results and guidance typically re‑rate shares; estimated conservative release date used based on historical cadence.
Prob 90% • Move 3% • Priced-in 50%

Long-term Catalysts

Months to a year

Margin expansion from product mix & cost actions
2027-02-19
Sustained margin gains from new-product mix and cost saves could support multi‑quarter multiple expansion; set one-year horizon to capture effect.
Prob 40% • Move 15% • Priced-in 20%

Risks

Adverse regulatory rulings or delayed approvals
Execution risk on cost actions and integration
Procedure-volume slowdown in core markets
Reimbursement cuts or pricing pressure

Peers

Symbol	Summary
SYK	Stryker — orthopedics and spine competitor; comparable product cycles and exposure to hospital capital spending.
BSX	Boston Scientific — interventional devices peer with similar sensitivity to procedure volumes and reimbursement trends.
ABT	Abbott — diversified medtech with diagnostics exposure; useful contrast on recurring-revenue and US/EM demand resilience.
JNJ	Johnson & Johnson — broader healthcare conglomerate; relevant for scale, diversification and capital-allocation benchmarking.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment AI
Human targets: serper
Targets query: Medtronic Plc Common (MDT) analyst consensus price target high low average
Analysis date: 2026-02-19